Cancer immunotherapy moves from dogs to human trials

Posted on June 7, 2015

From FierceAnimalHealth: Australia’s Regeneus has won regulatory approval to test a cancer therapy that it first pioneered for use in dogs with cancer. It’s a personalized cancer vaccine created from each patient’s tumor cells, which are combined with a medicine that’s designed to activate the immune system. Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *